Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · May 23, 2023

Renin–Angiotensin System Modulation With Synthetic Angiotensin (1–7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19

JAMA: The Journal of the American Medical Association

 

Additional Info

JAMA: The Journal of the American Medical Association
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials
JAMA 2023 Apr 11;329(14)1170-1182, WH Self, MS Shotwell, KW Gibbs, M de Wit, DC Files, M Harkins, KM Hudock, LH Merck, A Moskowitz, KD Apodaca, A Barksdale, B Safdar, A Javaheri, JM Sturek, H Schrager, N Iovine, B Tiffany, IS Douglas, J Levitt, LW Busse, AA Ginde, SM Brown, DN Hager, K Boyle, A Duggal, A Khan, M Lanspa, P Chen, M Puskarich, D Vonderhaar, L Venkateshaiah, N Gentile, Y Rosenberg, J Troendle, AJ Bistran-Hall, J DeClercq, R Lavieri, MM Joly, M Orr, J Pulley, TW Rice, JS Schildcrout, MW Semler, L Wang, GR Bernard, SP Collins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading